AtriCure Historical Balance Sheet
ATRC Stock | USD 36.17 0.38 1.06% |
Trend analysis of AtriCure balance sheet accounts such as Total Stockholder Equity of 489.5 M, Other Assets of 0.95 or Common Stock Shares Outstanding of 24.2 M provides information on AtriCure's total assets, liabilities, and equity, which is the actual value of AtriCure to its prevalent stockholders. By breaking down trends over time using AtriCure balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining AtriCure latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AtriCure is a good buy for the upcoming year.
AtriCure Inventory |
|
AtriCure |
About AtriCure Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of AtriCure at a specified time, usually calculated after every quarter, six months, or one year. AtriCure Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AtriCure and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AtriCure currently owns. An asset can also be divided into two categories, current and non-current.
AtriCure Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of AtriCure assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AtriCure books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Capital Lease Obligations
AtriCure capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to AtriCure asset purchases. For example, AtriCure can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as AtriCure control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Most accounts from AtriCure's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into AtriCure current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.At present, AtriCure's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 644.6 M, whereas Retained Earnings are projected to grow to (339.2 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Stockholder Equity | 483.8M | 456.8M | 466.2M | 489.5M | Total Assets | 615.3M | 585.4M | 613.9M | 644.6M |
AtriCure balance sheet Correlations
Click cells to compare fundamentals
AtriCure Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AtriCure balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 557.9M | 714.5M | 615.3M | 585.4M | 613.9M | 644.6M | |
Total Stockholder Equity | 247.3M | 412.4M | 483.8M | 456.8M | 466.2M | 489.5M | |
Retained Earnings | (282.2M) | (330.4M) | (280.2M) | (326.6M) | (357.1M) | (339.2M) | |
Other Assets | 705K | 16.5M | 955K | 2.0M | 1.0 | 0.95 | |
Common Stock Shares Outstanding | 37.6M | 42.1M | 46.0M | 45.7M | 46.3M | 24.2M | |
Liabilities And Stockholders Equity | 557.9M | 714.5M | 615.3M | 585.4M | 613.9M | 644.6M | |
Other Stockholder Equity | 529.7M | 742.4M | 764.8M | 787.4M | 824.2M | 865.4M | |
Total Liab | 310.5M | 302.1M | 131.6M | 128.7M | 147.8M | 80.4M | |
Other Current Liab | 32.8M | 28.5M | 34.6M | 36.4M | 44.7M | 46.9M | |
Total Current Liabilities | 49.9M | 49.1M | 56.4M | 58.4M | 74.6M | 78.3M | |
Accounts Payable | 14.9M | 12.7M | 18.6M | 19.9M | 27.4M | 28.7M | |
Cash | 28.5M | 41.9M | 43.7M | 58.1M | 84.3M | 88.5M | |
Inventory | 29.4M | 35.0M | 39.0M | 45.9M | 67.9M | 71.3M | |
Other Current Assets | 3.9M | 4.3M | 5.0M | 5.5M | 8.6M | 9.0M | |
Common Stock | 40K | 45K | 46K | 47K | 48K | 28.1K | |
Property Plant Equipment | 32.6M | 28.3M | 36.2M | 42.6M | 49.0M | 51.5M | |
Property Plant And Equipment Net | 36.7M | 30.2M | 36.2M | 42.6M | 46.8M | 49.1M | |
Net Debt | 47.9M | 32.1M | 32.0M | 11.0M | (9.8M) | (9.3M) | |
Non Current Assets Total | 414.7M | 407.8M | 419.2M | 370.2M | 347.7M | 365.1M | |
Non Currrent Assets Other | 705K | 440K | 955K | 2.0M | 2.2M | 2.3M | |
Cash And Short Term Investments | 81.8M | 244.2M | 119.1M | 121.1M | 137.3M | 144.1M | |
Net Receivables | 28.0M | 23.1M | 33.0M | 42.7M | 52.5M | 55.1M | |
Common Stock Total Equity | 40K | 45K | 46K | 47K | 54.1K | 28.2K | |
Non Current Liabilities Total | 260.6M | 253.0M | 75.1M | 70.3M | 73.2M | 60.0M | |
Property Plant And Equipment Gross | 36.7M | 30.2M | 36.2M | 42.6M | 99.2M | 104.1M | |
Total Current Assets | 143.2M | 306.7M | 196.1M | 215.2M | 266.2M | 279.6M | |
Accumulated Other Comprehensive Income | (158K) | 312K | (948K) | (4.1M) | (993K) | (943.4K) | |
Short Long Term Debt Total | 76.4M | 74.0M | 75.6M | 69.1M | 74.5M | 78.2M | |
Long Term Debt | 59.6M | 53.4M | 59.7M | 56.8M | 60.6M | 63.6M | |
Short Term Investments | 53.3M | 202.3M | 75.4M | 63.0M | 53.0M | 40.8M | |
Short Term Debt | 2.2M | 6.7M | 1.8M | 2.1M | 2.5M | 2.2M | |
Intangible Assets | 129.9M | 128.2M | 43.0M | 39.3M | 64.0M | 36.9M | |
Other Liab | 186.4M | 187.4M | 1.2M | 1.2M | 1.4M | 1.3M | |
Net Tangible Assets | (117.3M) | 49.4M | 206.0M | 182.6M | 210.0M | 220.5M | |
Retained Earnings Total Equity | (282.2M) | (330.4M) | (280.2M) | (326.6M) | (294.0M) | (308.7M) | |
Long Term Debt Total | 59.6M | 53.4M | 59.7M | 56.8M | 65.4M | 34.9M | |
Capital Surpluse | 529.7M | 742.4M | 764.8M | 787.4M | 905.5M | 470.9M | |
Non Current Liabilities Other | 201.0M | 199.6M | 15.4M | 13.5M | 1.2M | 1.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share 9.564 | Quarterly Revenue Growth 0.179 | Return On Assets (0.04) | Return On Equity (0.08) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.